These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina. Piver MS; Barlow JJ; Xynos FP Am J Obstet Gynecol; 1978 Jun; 131(3):311-3. PubMed ID: 78671 [TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy of carcinoma of the vulva and vagina. Current approaches]. Sesti F; Ciancio F; Bancheri C; Iannarilli P; Silvestri C; Piccione E G Ital Oncol; 1989; 9(4):117-20. PubMed ID: 2693347 [TBL] [Abstract][Full Text] [Related]
24. The Reynold L. Haas Memorial Lecture: gynecologic curiosities and concepts. Abell MR Univ Mich Med Cent J; 1969; 35(1):1-9. PubMed ID: 4305355 [No Abstract] [Full Text] [Related]
27. [Association of radiotherapy and chemotherapy: targeted therapies in gynecological cancers]. Barillot I; Haie-Meder C Bull Cancer; 2009 Mar; 96(3):271-83. PubMed ID: 19318305 [TBL] [Abstract][Full Text] [Related]
28. Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study. Slayton RE; Blessing JA; Beecham J; DiSaia PJ Cancer Treat Rep; 1987 Sep; 71(9):869-70. PubMed ID: 3621221 [No Abstract] [Full Text] [Related]
29. Female genital tract tumors in childhood and adolescence. Lang WR; Ng AB Clin Obstet Gynecol; 1971 Dec; 14(4):1013-25. PubMed ID: 5169569 [No Abstract] [Full Text] [Related]
31. [Proliferative kinetics of human genital carcinoma following the action of cytostatics and hormones in in vivo tests]. Heckmann U; Hamann A; Inamoto E Zentralbl Gynakol; 1969 Aug; 91(33):1057-61. PubMed ID: 5368199 [No Abstract] [Full Text] [Related]
33. Carcinoma in situ of the vagina. Hummer WK; Mussey E; Decker DG; Dockerty MB Am J Obstet Gynecol; 1970 Dec; 108(7):1109-16. PubMed ID: 5479689 [No Abstract] [Full Text] [Related]
34. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study. Muss HB; Bundy BN; Christopherson WA Am J Clin Oncol; 1989 Apr; 12(2):142-4. PubMed ID: 2705404 [TBL] [Abstract][Full Text] [Related]
35. Cytohistologic correlation in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix. Results of utilizing cytologic nomenclature based on standard histologic terminology. Konikov NF; Kempson RL; Piskie V Am J Clin Pathol; 1969 Apr; 51(4):463-9. PubMed ID: 5774661 [No Abstract] [Full Text] [Related]
36. Classification and staging of gynecologic malignancies. ACOG Technical Bulletin Number 155--May 1991 (replaces No. 47, June 1977). Int J Gynaecol Obstet; 1992 Aug; 38(4):319-23. PubMed ID: 1358693 [No Abstract] [Full Text] [Related]
37. [Resistance formation in the cytostatic treatment of carcinomas]. Heckmann U; Tranckjer AS; Harms J Zentralbl Gynakol; 1969 Sep; 91(37):1204-10. PubMed ID: 5368211 [No Abstract] [Full Text] [Related]
38. Localized neurofibromatosis of the female genitourinary tract. Gersell DJ; Fulling KH Am J Surg Pathol; 1989 Oct; 13(10):873-8. PubMed ID: 2506770 [TBL] [Abstract][Full Text] [Related]
39. Regional chemotherapy--a comparison of pelvic perfusion and intra-arterial infusion in patients with advanced gynecologic cancer. Cavanagh D; Hovadhanakul P; Comas MR Am J Obstet Gynecol; 1975 Oct; 123(4):435-41. PubMed ID: 1166867 [TBL] [Abstract][Full Text] [Related]